SimpleStep Atom Review

Carboplatin Paclitaxel

ovarian/carboplatin_paclitaxel · 6 cycles · 21-day cycle

Generated 4/26/2026, 9:25:13 PM

How to review

Each card below is one TEACH encounter — the patient sees TUNE, then EXPLAIN, then ACKNOWLEDGE, then CONFIRM, then HANDOFF, in order.

Type feedback in the boxes under each section. When you're done, click Download feedback at the bottom — it'll save a markdown file with everything you wrote, that you can email back.

Things to watch for: voice fit (does it sound like SimpleStep?), language tone (anything cold, bossy, or off?), missing emotional register, redundancy across sections, anything that lands wrong.

Cycle 1 · Day 1 EDUCATION gate: soft

Treatment Overview

TUNE Tune in to readiness ovarian-carbo-taxol.treatment_overview.tune

An ovarian cancer diagnosis often arrives suddenly — vague symptoms, then everything moves fast. Showing up here is taking action, not letting things happen to you.

You may already know chemotherapy is medicine that targets cancer cells. Today we'll connect that to YOUR specific treatment for ovarian cancer.

Question for you: Before we start: what have you already heard about your treatment plan?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Thanks — that helps me know where to start. What questions do you have so far?
Sources
  • cache/openfda/carboplatin.json (indications: initial treatment of advanced ovarian carcinoma)
  • cache/openfda/paclitaxel.json (indications: advanced carcinoma of the ovary)
  • cache/pdq/ovarian-treatment-patient.json (PDQ: ovarian epithelial/fallopian/peritoneal — patient version)
  • research/Interview-1: scaffold-on-familiar; ovarian-dx-arrives-suddenly framing

Foundation TUNE — patient's first contact with the regimen. Surfaces prior knowledge before EXPLAIN. Disease-framed: ovarian-specific emotional arc, regimen-tier scope so the disease framing is justified.

EXPLAIN Explain essentials ovarian-carbo-taxol.treatment_overview.explain

Three things to know about your treatment: the medicines, the schedule, and why they're paired.

Two medicines, two ways

Carboplatin damages cancer cell DNA so cells can't multiply. Paclitaxel stops cells from dividing. Together they reach cancer in two different ways.

Day 1 of every 21 days

Both drugs are given on Day 1. Your first visit takes 6 to 8 hours because the paclitaxel is given slowly to watch for allergic reactions. Later visits are shorter. Cycles repeat every 21 days, usually 6 cycles total.

Standard first-line treatment

This pair has been the backbone of ovarian cancer treatment for decades. It works. You're getting the same regimen most newly diagnosed patients receive — proven and predictable.

Sources
  • cache/openfda/carboplatin.json (mechanism: DNA crosslinking; indications: initial treatment of advanced ovarian carcinoma)
  • cache/openfda/paclitaxel.json (mechanism: stabilizes microtubules / inhibits cell division; ovarian indication; pre-medication and slow infusion to mitigate hypersensitivity)
  • cache/medlineplus/carboplatin.json (cycle interval; common side effects; patient-facing language)
  • cache/medlineplus/paclitaxel.json (cycle interval; pre-medications; patient-facing language)
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (voice anchor)

Side effects deferred to their own scheduled atoms (sequential mastery). Duration corrected to 6-8h for C1 (slow paclitaxel drip per FDA label). KP3 BRCA/HRD reference removed — scaffold violation; patient has no prior context for those terms.

ACKNOWLEDGE Acknowledge emotion carbo-taxol.treatment_overview.acknowledge

Before it happens

Most patients feel anxious in the chair before the first infusion. That anxiety is normal — it doesn't mean something is wrong. Having a person with you, music, or a book helps. You don't have to be brave today. You just have to show up.

For you

Today is your longest visit — 6 to 8 hours. The paclitaxel is given slowly the first time so we can watch for any allergic reactions. Once we know you tolerate it well, later visits are shorter. Bring something to read, a snack, and someone with you. Most patients feel okay during the visit itself; symptoms usually start a day or two later.

For your support person

Plan to drive your patient home — the pre-medications can cause drowsiness. Stock the kitchen ahead of time: crackers, ginger ale, broth, popsicles. Pick up the anti-nausea prescription before today and have it ready at home.

Sources
  • cache/openfda/paclitaxel.json (premedication: corticosteroids, diphenhydramine, H2 antagonists; slow infusion to mitigate hypersensitivity 2-4%)
  • cache/openfda/carboplatin.json (vomiting as frequent drug-related side effect)
  • cache/medlineplus/paclitaxel.json (drowsiness from premeds; have a driver)
  • research/Interview-1: emotional pre-rehearsal at foundation; storm-prep at home

Drug-pair scope (no disease tag) — content describes the carbo+taxol experience itself: 6-8h C1 day, premed drowsiness, slow paclitaxel drip. Applies anywhere this drug pair is given. Caregiver pronouns degendered to 'your patient' so atom resolves cleanly for non-ovarian carbo+taxol regimens (lung, endometrial, etc.).

CONFIRM Confirm understanding carbo-taxol.treatment_overview.confirm

teach_caregiver

Pretend your support person is asking about your treatment. In one or two sentences, tell them what the two medicines do, and how often you'll get them.

[ patient explains aloud to caregiver · "Tap when done" button · optional "I'm by myself" → switches to typed answer ]
Sources
  • research/interview-2: 'teach it to your caregiver' as confirmation method
  • research/Why_TEACH_Is_Not_Teach_Back.md (application-based confirmation; no graded recall)
  • cache/openfda/carboplatin.json + cache/openfda/paclitaxel.json (mechanism + 21-day cycle the patient is restating)

Drug-pair scope (no disease) — content asks the patient to teach back the medicines + schedule, both regimen-level facts. teach_caregiver chosen over confidence_slider per TEACH research; correct_feedback shown unconditionally as model framing. Side-effect timing intentionally NOT in the prompt — wasn't taught in this EXPLAIN.

HANDOFF Handoff with homework universal.treatment_overview.handoff

One line to remember: Today's visit is long, but the real work is at home. We'll prepare you for it together, one step at a time.

Homework: Save your clinic number and after-hours number in your SimpleStep profile now — one tap away if you ever need them at 2am.

▶ In-app action (required to dismiss)
save phone numbers

Coming next: Next we'll cover the most important thing about the days after treatment: when to call us.

Before you leave: Before you go — what questions do you have about today?

Sources
  • research/Interview-1/02_Storm_Prep_Checklist_Patient.md (save numbers as foundational storm-prep)
  • research/Interview-1: 'practice before the storm' generator-drill principle

Universal scope — homework (save clinic numbers) and open_loop (when to call) apply to any first treatment_overview encounter, regardless of regimen or disease. Open_loop intentionally generic (no fever-specific cue) so the atom resolves cleanly across regimens whose next safety topic varies. exit_ticket replaces prior 'show me how you'd call' with the canonical 'what questions do you have' framing.

Cycle 1 · Day 1 SAFETY gate: hard

Infusion Reactions

TUNE Tune in to readiness carbo-taxol.infusion_reactions.tune

Most people don't have a reaction. Some do. We pre-medicate, and the team watches you the whole time. Speaking up early makes it manageable.

If you've ever had an allergic reaction — bee sting, food, a medicine — same idea here, just with us in the room.

Question for you: Any allergic reactions in your history — medicines, foods, stings?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Thanks — we'll flag that in the chart.
Sources
  • openFDA paclitaxel boxed warning: anaphylaxis 2-4% despite premedication; corticosteroids/diphenhydramine/H2 antagonists required
  • openFDA carboplatin boxed warning: anaphylactic-like reactions within minutes
  • research/Interview-1: scaffold-on-familiar (prior allergic reaction experience)

Drug-pair scope. Distinct from hypersensitivity (C5+ cumulative reaction): this is acute first-dose. Open-text rapid assessment captures prior allergy history for downstream safety.

EXPLAIN Explain essentials carbo-taxol.infusion_reactions.explain

Three things to know: how often, what it looks like, and what to do.

Two to four out of a hundred

About two to four people in a hundred have an infusion reaction to paclitaxel. We give you steroids, an antihistamine, and a stomach blocker before chemo to lower that risk.

Watch for these signals

Flushing, tightness in your chest or throat, trouble breathing, itchiness, a racing heart, or back pain. Most reactions start in the first ten to fifteen minutes.

Tell us early — anything counts

Don't wait to be sure. A small tickle is enough. We can pause, give more medicine, and most of the time keep going. Telling us late is what limits options.

Sources
  • openFDA paclitaxel boxed warning: anaphylaxis 2-4% in clinical trials; symptoms include dyspnea, hypotension, angioedema, urticaria
  • openFDA carboplatin boxed warning: anaphylactic-like reactions within minutes of administration
  • research/Interview-1: 'tell us early — anything counts' framing reduces under-reporting

Three key points map to: incidence, signs, action. The 2-4% number is FDA-derived. Symptom list matches both labels' boxed warnings. 'Telling us late limits options' is the load-bearing message — under-reporting is the dominant risk.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.infusion_reactions.acknowledge

Before it happens

Mid-infusion, if something feels off, you're going to want to wait it out — not interrupt the nurse, not seem dramatic, not be the patient who panicked over nothing. That impulse to wait is your signal to speak up. The nurse would much rather pause for nothing than miss something.

Practice scenario

Practice now: It's twelve minutes into your first paclitaxel. Your chest feels tight, your face is warm. Step 1: raise your hand. Step 2: say 'I'm feeling something — can you check?' That's it. They take it from there.

For you

Carbo and paclitaxel are the two most common drugs in ovarian chemo, and reactions are most likely on Day 1, in the first fifteen minutes of paclitaxel. The team is at the chair. Pre-meds make it less likely. Speaking up makes it manageable.

For your support person

If you're with her at the first infusion, sit where she can catch your eye. If she goes quiet or looks flushed and says she's fine, ask the nurse to check anyway. You're not overstepping — you're paying attention while she's busy holding still.

Sources
  • openFDA paclitaxel: reactions within first 10 min of infusion, mostly first/second cycle
  • openFDA carboplatin: anaphylactic-like reactions within minutes
  • research/interview-2: under-reporting pattern (don't want to seem dramatic)
  • research/Interview-1/02_Storm_Prep_Checklist_Patient.md: generator drill format

Safety priority — both pre_rehearsal and generator_drill present per validator rules. Pre-rehearsal names the under-reporting impulse (don't be dramatic) before it happens at the chair. Caregiver context targets the 'silent suffering' moment when patient says 'I'm fine'.

CONFIRM Confirm understanding carbo-taxol.infusion_reactions.confirm

binary_decision

Ten minutes into your first paclitaxel infusion, you feel a small tickle in the back of your throat. The nurse is busy with another patient. What do you do?

  • Wait — it's probably nothing
  • Tell the nurse now ←
Sources
  • openFDA paclitaxel: hypersensitivity reactions typically within first 10 minutes
  • research/Comprehension_Gaps: 'don't want to bother the nurse' is the dominant under-reporting pattern
  • research/Interview-1: binary decision tests most-common-wrong-answer (waiting it out)

Drug-pair scope. Tests the 'wait and see' wrong-answer pattern. Incorrect feedback is mechanism-focused (early signs are exactly what the team needs).

HANDOFF Handoff with homework universal.infusion_reactions.handoff

One line to remember: Anything that feels off during an infusion — tickle, flush, tightness — say it out loud, right then.

Homework: Before your next infusion, know where the nurse call button is and tell your nurse you're a 'speak up early' person. That sets the tone.

Before you leave: Before you go — what's the one thing you do if something feels off mid-infusion?

Sources
  • openFDA paclitaxel: most reactions within first 10 minutes — early reporting critical
  • openFDA carboplatin: anaphylactic-like reactions within minutes
  • research/Interview-1: 'speak up early' as identity, not exception

Universal scope: applies to any infusion-based regimen. No regimen-specific timing details. Open_loop omitted (no schedule context to preview from a universal atom).

Cycle 1 · Day 1 EDUCATION gate: soft

Nausea Prevention

TUNE Tune in to readiness carbo-taxol.nausea_prevention.tune

Nausea is what worries most people most. It's also what we have the most tools for — and the plan starts before you feel anything.

You already know what nausea feels like — flu, food poisoning, maybe pregnancy. Same instinct, earlier.

Question for you: What's worked for you in the past when you've felt nauseous?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Good — we'll keep what works for you and add the medications on top.
Sources
  • openFDA carboplatin: vomiting listed as frequent drug-related side effect
  • openFDA paclitaxel: nausea/vomiting common in carbo+paclitaxel combination
  • MedlinePlus carboplatin: side effects include nausea/vomiting
  • research/Interview-1: scaffold-on-familiar (prior nausea experience)

Drug-pair scope: applies to any regimen using carboplatin+paclitaxel. Scaffold leverages near-universal prior nausea experience. Open-text rapid assessment captures patient's existing anti-nausea strategies for downstream personalization.

EXPLAIN Explain essentials carbo-taxol.nausea_prevention.explain

Three things about nausea: when it tends to hit, how the medicines work, and the line we don't cross.

Worst window is the first few days

Nausea from carboplatin and paclitaxel usually peaks one to three days after each infusion, then eases. Most people feel close to normal by the end of the first week.

Pills on schedule, not on symptoms

We give IV anti-nausea medicine before chemo and send pills home. Take the home pills on the clock, even if you feel fine — preventing nausea works far better than chasing it.

Call before you stop drinking

If you can't keep liquids down for twelve hours, that is the line. Call us before dehydration sets in. We can adjust your medicines or bring you in for IV fluids.

Sources
  • openFDA carboplatin: vomiting listed as frequent drug-related side effect; pretreatment with antiemetics standard
  • openFDA paclitaxel: nausea/vomiting reported in clinical trials
  • MedlinePlus carboplatin: schedule of antiemetic medications
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-N-01): 'on schedule, even if you feel fine' framing

Three key points map to: timing, mechanism, escalation. 'Pills on schedule not symptoms' is the load-bearing message — patients commonly skip doses when feeling fine and end up chasing breakthrough nausea. The 12-hour fluid threshold is the actionable call-us trigger from chemo-card.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.nausea_prevention.acknowledge

For you

For most ovarian patients on carbo and paclitaxel, the nausea peak hits twenty-four to seventy-two hours after each infusion — when the steroid taper ends and you feel a wave you weren't expecting. That dip is predictable. The plan handles it. You are not failing the plan if you feel sick — you're hitting the spot the medications are built for.

For your support person

Day two and three are when she may need you most. Set a phone alarm for each scheduled anti-nausea pill — the pattern is easy to lose track of. Stock popsicles, ginger ale, and crackers near the bed. If she skips fluids more than half a day, ask once, gently, and then call us together.

Sources
  • openFDA carboplatin: emetogenicity profile and dexamethasone premedication
  • openFDA paclitaxel: dexamethasone premedication standard
  • research/Interview-1: caregiver-action specificity (alarms, bedside supplies, fluid threshold)
  • research/Emotional_Journey_Map: 'feeling sick = failing' patient anxiety pattern

Education priority — no emotional_pre_rehearsal or generator_drill required. Patient context names the predictable steroid-taper rebound dip (clinical reality patients often interpret as personal failure). Caregiver context is concrete actions per skill rules — alarms, supplies, threshold for escalation.

CONFIRM Confirm understanding ovarian-carbo-taxol.nausea_prevention.confirm

binary_decision

It's the morning after your infusion. You feel completely fine. Your next anti-nausea pill is due in ten minutes. What do you do?

  • Take it on schedule ←
  • Skip it — save it for when I feel sick
Sources
  • openFDA carboplatin/paclitaxel: scheduled antiemetic regimen (not PRN)
  • research/Comprehension_Gaps: 'feeling fine = skip dose' is the most common error pattern
  • research/Interview-1: binary criteria reduce judgment burden when patient is symptomatic

Tests the most common wrong answer (skip when feeling fine). Binary format for low-judgment-burden tap. Incorrect feedback is shame-free, mechanism-focused (pharmacokinetic level drops if doses are skipped).

HANDOFF Handoff with homework ovarian-carbo-taxol.nausea_management.handoff

One line to remember: Stay ahead of nausea — take your anti-nausea pills on schedule, before you start to feel sick.

Homework: Rate your nausea once today, even if it's a 0. We'll save it as your starting point so any change stands out tomorrow.

▶ In-app action (required to dismiss)
log symptom
{
  "symptom_type": "nausea",
  "alert_threshold": 7
}

Coming next: On Day 3 we'll cover fever — the most important call-us symptom of all.

Before you leave: Before you go — what's your nausea right now, 0 to 10?

Sources
  • openFDA carboplatin label: vomiting is a frequent drug-related side effect
  • openFDA paclitaxel label: nausea/vomiting common with paclitaxel + carboplatin combination
  • next_slots: fever_neutropenia at C1D3 — open_loop directly cues
  • TEACH framework: HANDOFF homework as active assignment with structured action

Single HANDOFF authored to surface the log_symptom homework_action for proof testing. Full TEACH set (TUNE/EXPLAIN/ACKNOWLEDGE/CONFIRM) deferred to a follow-up authoring pass.

Cycle 1 · Day 3 SAFETY gate: hard

Fever Neutropenia

TUNE Tune in to readiness ovarian-carbo-taxol.fever_neutropenia.tune

One thing we should prepare for is what to do if you get a fever during chemotherapy. Most patients won't need this — but we want you ready.

You already know to check your temperature when you feel off — that's the same skill we need here.

Question for you: If you've ever been sick before and needed to check for a fever, how did you do it?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Good — you already know the basic move. We'll make it routine here.
Sources
  • research/Interview-1: 'You already know to check your temperature' verbatim scaffold
  • research/Sequential_Mastery_Map: foundation atom for fever education

Scaffold hook quotes Erica's interview directly — most patients have managed a fever before chemo, surface that competence.

EXPLAIN Explain essentials ovarian-carbo-taxol.fever_neutropenia.explain

Three things to know about fever during treatment: the number, the reason, and the action.

100.4 means call us

A temperature of 100.4°F (38.0°C) or higher is the threshold. Don't wait. Don't take Tylenol first. Don't tell yourself it's nothing. Just call.

Your blood counts drop around days 7 to 14

Carboplatin and paclitaxel lower the white blood cells that fight infection. The lowest point is roughly Day 11 — you won't feel it. A fever during this window is how an infection shows up.

Calling early is what protects you

When you call, we can act fast — assess your counts and start treatment if you need it. The earlier we know, the more options we have. That's why the 'just call' rule has no exceptions.

Sources
  • openFDA: paclitaxel (neutrophil nadir median day 11)
  • openFDA: carboplatin (median nadir day 21 single agent; combination earlier)

≤3 key points per research volume rules. Used paclitaxel nadir (day 11) as the dominant signal since it's the earlier of the two. Per Kevin's clinical correction (2026-04-25): dropped the 'antibiotics within an hour' framing — that 60-minute target is extrapolated from inpatient ER sepsis bundles and doesn't apply to outpatient education. The right message is 'call early so we can move fast', not a specific time-bound antibiotic promise that would build a false expectation.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.fever_neutropenia.acknowledge

Before it happens

When you have a fever at 2am, you're going to want to talk yourself out of calling. You'll feel like you're overreacting. You'll worry about bothering the doctor in the middle of the night. That feeling is your signal to pick up the phone — not your signal to wait.

Practice scenario

Practice now: It's 11pm. You feel warm and check your temp: 100.6°F. Step 1: stop. Step 2: pick up your phone. Step 3: call the after-hours number. That's it — we take it from there.

For you

Today is Day 3 — your blood counts are still mostly normal. We're teaching you now, while you feel okay, so the answer is ready. The risk window peaks around Day 11. The rule is the same all the way through: 100.4 = call.

For your support person

Print the after-hours number and put it on the fridge today. Put the thermometer somewhere you can find it at 2am. If she has chills and won't take her temperature, take it for her. If it's 100.4 or higher, you make the call if she hesitates.

Sources
  • research/interview-2: emotional pre-rehearsal verbatim quote — 2am fever scenario
  • research/Interview-1/02_Storm_Prep_Checklist_Patient.md: generator drill format
  • research/Comprehension_Gaps: 'social anxiety' barrier (don't want to bother doctor) is more dangerous than knowledge gap
  • openFDA: paclitaxel (median nadir day 11)

Emotional pre-rehearsal is the load-bearing piece for safety atoms — names the future hesitation before it arrives so the patient recognizes it in the moment.

CONFIRM Confirm understanding ovarian-carbo-taxol.fever_neutropenia.confirm

binary_decision

It's 2am. You feel warm. Your temperature reads 100.6°F. Should you take Tylenol and see if the fever goes down before calling?

  • Yes — try Tylenol first
  • No — call the after-hours number ←
Sources
  • research/Interview-1/02_Storm_Prep_Checklist_Patient.md: 'Don't take Tylenol first. Just call.'
  • research/interview-2: binary criteria reduce judgment burden under stress

Binary decision tests the most common wrong answer (Tylenol first). Incorrect feedback is shame-free, educator's-clarification framed.

HANDOFF Handoff with homework ovarian-carbo-taxol.fever_neutropenia.handoff

One line to remember: 100.4°F or higher = call immediately, any time, no exceptions, no Tylenol first.

Homework: Log your temperature once today in the app. We're getting your normal range on the page so a fever stands out.

▶ In-app action (required to dismiss)
log temperature

1× per day · alert at ≥100.4°F

Coming next: On Day 5 we'll cover what's normal but unpleasant — fatigue and muscle aches — so you can tell those apart from the call-us symptoms.

Before you leave: Before you go — what number do you call at 2am, and what's the fever threshold?

Sources
  • research/Interview-1/04_Sequential_Mastery_Map.md: temperature-tracking homework
  • next_slots: fatigue + muscle_aches at C1D5 — open_loop directly cues
  • research/Interview-1: 'establish your normal so a fever stands out' principle

Homework establishes pre-fever baseline. Open loop directly previews next-scheduled topics so the patient knows what's coming.

Cycle 1 · Day 3 EDUCATION gate: soft

Lab Monitoring

TUNE Tune in to readiness carbo-taxol.lab_monitoring.tune

Labs before each cycle can feel like one more appointment. They're actually the most important one — they're how we make sure each dose is safe and right-sized for you.

You've had blood drawn before — annual physical, surgery prep. Same blood draw, doing more work now.

Question for you: What did your labs look like at your last appointment — anyone explain them to you?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Good — we'll connect that to today's numbers.
Sources
  • openFDA carboplatin: peripheral blood counts must be frequently monitored; dose-adjusted by kidney function
  • openFDA paclitaxel: frequent peripheral blood cell counts required
  • research/Interview-1: scaffold-on-familiar (prior blood draw)

Drug-pair scope. Reframes labs from 'extra hassle' to 'safety check'. Open-text rapid assessment surfaces existing literacy.

EXPLAIN Explain essentials carbo-taxol.lab_monitoring.explain

Three numbers we watch most: blood counts, kidney function, and platelets.

Blood counts decide if today's a chemo day

We need your white blood cells and platelets above a safety threshold before each cycle. If they're not, we wait a week. Waiting is not falling behind — it's protecting you.

Kidney function sets your carboplatin dose

Carboplatin is dosed from your kidney function, not just your weight. The number, called creatinine, tells us how much to give. That's why labs are pre-chemo, not after.

You don't need to memorize the numbers

Your team will tell you if anything's off and what we're doing about it. Your job is to show up and ask one question: 'Anything I should know about today's labs?'

Sources
  • openFDA carboplatin: dose calculated using Calvert formula based on creatinine clearance; bone marrow suppression dose-limiting
  • openFDA paclitaxel: ANC > 1500 required; platelet recovery > 100,000 required between cycles
  • research/Interview-1: 'one question to ask' format reduces learning burden

Three key points: counts (proceed/delay), kidney function (dose), patient action (one question). Avoids overwhelming patient with normal ranges. Calvert formula reference is for provenance only — patient does not need it.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.lab_monitoring.acknowledge

For you

For ovarian patients on carbo and paclitaxel, your blood counts will dip around Day eleven and recover before the next cycle. We schedule labs the day before chemo for a reason — late-stage prep, not catching up. If a cycle gets delayed, that's the system working right, not you falling behind.

For your support person

Lab days are short but tiring. Drive her if you can. Bring water and a snack — fasting isn't required for these labs. If the team mentions a delay, write down what they said about why; she may not remember by the car ride home.

Sources
  • openFDA paclitaxel: median nadir at day 11; recovery required for next cycle
  • openFDA carboplatin: nadir later in single-agent; combination therapy similar
  • research/Emotional_Journey_Map: 'delay = falling behind' patient anxiety pattern
  • research/Interview-1: caregiver-action specificity (drive, snacks, write down)

Education priority — pre_rehearsal/drill optional. Patient context names the delay-anxiety pattern. Caregiver context targets the post-appointment recall gap (patients commonly forget what was said by the time they're home).

CONFIRM Confirm understanding ovarian-carbo-taxol.lab_monitoring.confirm

binary_decision

Your nurse calls — your white blood cells are too low to do chemo today. She says they want to wait a week. How does that feel to you?

  • Like I'm falling behind
  • Like the system is working ←
Sources
  • openFDA carboplatin/paclitaxel: count recovery required between cycles
  • research/Emotional_Journey_Map: 'falling behind' is the dominant misinterpretation of cycle delays
  • research/Interview-1: binary frame for shame-prone misinterpretations

Tests the 'falling behind' misinterpretation directly. Reframes delay as safety. Incorrect_followup makes the reframe portable.

HANDOFF Handoff with homework universal.lab_monitoring.handoff

One line to remember: Labs are the safety check that decides if a cycle goes — not extra paperwork.

Homework: At your next lab appointment, ask one question: 'Anything I should know about today's numbers?' That's the whole assignment.

Before you leave: Before you go — what's the one thing you ask at your next lab visit?

Sources
  • openFDA carboplatin/paclitaxel: lab monitoring required pre-cycle (universal across IV chemo)
  • research/Interview-1: 'one question' as homework lowers cognitive load

Universal scope: pre-cycle labs are standard across IV chemo regimens. No regimen-specific timing. Homework is one tiny action that compounds.

Cycle 1 · Day 5 EDUCATION gate: soft

Fatigue

TUNE Tune in to readiness ovarian-carbo-taxol.fatigue.tune

Patients commonly say 'I felt lazy' — it's not lazy. The fatigue is your body using energy on the chemo, not on you. That's biology, not character.

You know what regular tired feels like — bad night, late shift, jet lag. Chemo tired is a different animal. Naming it helps.

Question for you: What does a really tired day look like for you normally?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Good — we'll use that as your baseline.
Sources
  • openFDA paclitaxel: asthenia/fatigue listed as common adverse reaction
  • openFDA carboplatin: weakness reported in clinical trials
  • research/Emotional_Journey_Map: 'I felt lazy' verbatim — fatigue mistaken for personal failure
  • research/Interview-1: scaffold-on-familiar (regular vs chemo tired)

Regimen scope per coverage matrix. Reframes 'lazy' interpretation explicitly using verbatim patient language. Establishes a personal baseline for downstream fatigue tracking.

EXPLAIN Explain essentials ovarian-carbo-taxol.fatigue.explain

Three things about chemo fatigue: when it hits, what it isn't, and what actually helps.

Days four to seven are the dip

For carbo and paclitaxel, fatigue tends to peak around the end of the first week after each infusion. Sleep doesn't fix it the way sleep fixes regular tired.

It's not low blood counts

Chemo fatigue can happen even when your labs look fine. It's the body spending energy on healing. Don't wait for a number to confirm what you feel.

Short walks beat long naps

Counterintuitive but consistent: ten minutes of slow movement beats an hour in bed. Light activity, sunlight, and small protein meals help more than rest alone.

Sources
  • openFDA paclitaxel: fatigue/asthenia common adverse reaction
  • openFDA carboplatin: weakness reported
  • research/Interview-2: 'short walks beat long naps' patient-validated wisdom
  • research/Comprehension_Gaps: patients commonly conflate fatigue with anemia

Three key points: timing, mechanism (decoupled from labs), action. Counterintuitive 'walks > naps' is research-validated. Avoids medicalizing fatigue as anemia (common patient misconception that delays activity).

ACKNOWLEDGE Acknowledge emotion universal.fatigue.acknowledge

For you

Chemo fatigue catches people off guard because it doesn't feel like normal tired. You may sleep nine hours and still feel done by lunch. That isn't weakness or depression — it's your body doing real work in the background. The plan accommodates this. You're allowed to rest without earning it.

For your support person

Take one task off her plate this week without asking — laundry, dishes, school pickup, whatever. If she says 'I should be doing that,' just say 'next week.' Don't ask 'how are you feeling?' fifteen times. Quiet help reads as love; check-ins read as pressure.

Sources
  • research/Emotional_Journey_Map: 'permission to rest' as load-bearing phrase
  • research/Interview-1: caregiver action-not-words principle
  • research/Comprehension_Gaps: 'should be doing that' as universal patient guilt pattern

Universal scope: chemo fatigue is universal across IV regimens. Education priority — pre_rehearsal/drill optional. Patient context grants explicit permission to rest. Caregiver context gives one specific anti-pattern to avoid (checking-in fatigue) and one action to take.

CONFIRM Confirm understanding ovarian-carbo-taxol.fatigue.confirm

binary_decision

It's Day six. You're exhausted. You'd planned to walk around the block but you're tempted to spend the day in bed. What does the research say works better?

  • A long nap
  • A short, slow walk ←
Sources
  • research/Interview-2: 'short walks beat long naps' — patient-validated
  • openFDA paclitaxel/carboplatin: fatigue managed with activity rather than rest alone (general oncology-rehab consensus)

Tests the most common counterproductive choice (long nap). Binary frame matches the natural moment of decision (Day 6, tired). Incorrect_followup is portable.

HANDOFF Handoff with homework universal.fatigue.handoff

One line to remember: Chemo tired isn't lazy and isn't permanent. Five slow minutes a day beats waiting it out.

Homework: Pick one ten-minute movement window today — slow walk, stretching, sunlight on the porch. Log it in the app even if it felt small. Small counts.

▶ In-app action
log activity
{
  "min_minutes": 5
}

Before you leave: Before you go — what's your ten-minute movement plan for today?

Sources
  • research/Interview-2: 'short walks beat long naps' — patient-validated
  • research/Interview-1: log_activity homework as accountability without pressure

Universal scope: chemo fatigue management is regimen-agnostic. Homework is small (10 min) and optional log to avoid guilt-when-skipped. Open_loop omitted (universal atoms can't preview specific schedule).

Cycle 1 · Day 5 EDUCATION gate: soft

Muscle Aches

TUNE Tune in to readiness carbo-taxol.muscle_aches.tune

Aching all over on top of everything else feels like a setback. It's not — this kind of ache is the drug's footprint, and it fades.

You know the body-ache feeling from the flu, or two days after a hard workout. Paclitaxel can cause something similar.

Question for you: What's helped you with achy days in the past — heat, ibuprofen, movement, rest?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Good — most of those help here too. We'll personalize from there.
Sources
  • openFDA paclitaxel: myalgia/arthralgia listed as common adverse reaction
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-MYALGIA-01): timing peaks day 2-3
  • research/Interview-1: scaffold-on-familiar (flu-aches, post-workout soreness)

Drug-pair scope. Reframes aches as 'drug footprint, not setback' — patients commonly read body symptoms as treatment failure.

EXPLAIN Explain essentials carbo-taxol.muscle_aches.explain

Three things about muscle and joint aches: when, what helps, and when to call.

Days two to seven are the window

Paclitaxel-related aches usually start one to two days after infusion, peak around days two and three, and ease by day seven. Not everyone gets them; some cycles are worse than others.

Movement plus warmth plus medication

Gentle walking, stretching, warm baths, and a heating pad all help. Acetaminophen is fine; ask your team before adding ibuprofen — sometimes it's okay, sometimes not, depending on your platelets.

Call if it stops your day

If aches keep you from walking, sleeping, or eating, that's a call-us moment — not toughing-it-out. We can adjust your medications or add stronger options if needed.

Sources
  • openFDA paclitaxel: myalgia/arthralgia common; manageable with NSAIDs/acetaminophen
  • openFDA carboplatin: thrombocytopenia consideration for NSAID timing
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-MYALGIA-01): timeline and management

Three points: timeline, what helps, escalation. NSAID-with-conditions is important: low platelets contraindicate ibuprofen. Does not promise patient can take NSAIDs without checking.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.muscle_aches.acknowledge

For you

Day three after paclitaxel is when most ovarian patients feel this most — a bone-deep ache, especially in hips and thighs. It can get worse the day before it gets better. That climb-then-drop is normal for this regimen and isn't a sign of anything getting worse underneath.

For your support person

Day two through four, anticipate the dip. Pre-fill her water bottle, leave the heating pad on the bed, keep ibuprofen and acetaminophen visible. Ask the team once whether ibuprofen is okay this cycle — platelet counts can change the answer between cycles.

Sources
  • openFDA paclitaxel: myalgia/arthralgia peaks 24-72h post-infusion
  • openFDA carboplatin: thrombocytopenia varies cycle to cycle — NSAID safety is dynamic
  • research/Emotional_Journey_Map: 'getting worse before better' as missed-signal pattern
  • research/Interview-1: caregiver-action specificity

Education priority — pre_rehearsal/drill optional. Patient context names the climb-then-drop pattern (Day 3 worse than Day 2) which patients commonly read as deterioration. Caregiver context flags the cycle-to-cycle NSAID re-check.

CONFIRM Confirm understanding ovarian-carbo-taxol.muscle_aches.confirm

binary_decision

It's Day three. Your hips ache. You have ibuprofen in the cabinet from before chemo. Do you take it without asking?

  • Yes — it worked before
  • Check with the team first ←
Sources
  • openFDA carboplatin: thrombocytopenia (low platelets) cycle-variable
  • openFDA paclitaxel: bone marrow suppression
  • research/Comprehension_Gaps: 'I had it before' wrong-pattern with NSAIDs

Tests common error: assuming OTC is always safe because it was before. Mechanism explanation (platelets vary) makes the rule learnable, not arbitrary.

HANDOFF Handoff with homework universal.muscle_aches.handoff

One line to remember: Aches climb before they drop, peak around day three, and ease by day seven. That arc is the drug, not you.

Homework: Track your worst ache rating once a day this cycle, even if it's a zero. We use the pattern, not any single day, to plan adjustments.

▶ In-app action
log symptom
{
  "scale": "0_to_10",
  "symptom_type": "muscle_aches"
}

Before you leave: Before you go — what number is your ache today, and what helped most?

Sources
  • openFDA paclitaxel: myalgia/arthralgia peaks days 2-3, resolves day 5-7
  • research/Interview-1: pattern-tracking (not single-point) for symptom adjustment

Universal scope: muscle-ache management is regimen-agnostic for taxane regimens. Optional logging avoids guilt-when-skipped. Open_loop omitted (universal).

Cycle 1 · Day 7 EDUCATION gate: soft

Neuropathy

TUNE Tune in to readiness carbo-taxol.neuropathy.tune

Nerve changes are unsettling because you can't see them. Saying it out loud is what protects your function long-term — early reporting changes the math.

If your foot has ever fallen asleep, that pins-and-needles feeling — that's the early version of what we watch for here.

Question for you: Have you had any tingling, numbness, or hand weakness recently — even mild?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Thanks — even small changes are worth a note. We'll watch.
Sources
  • openFDA paclitaxel: peripheral neuropathy dose-cumulative; sensory predominant
  • openFDA carboplatin: peripheral neuropathy less common but reported
  • research/Interview-1: scaffold-on-familiar (foot-fell-asleep tingling)

Drug-pair scope. Pins-and-needles scaffold is universal somatic experience. Open-text rapid assessment captures early signs that patients may not volunteer.

EXPLAIN Explain essentials carbo-taxol.neuropathy.explain

Three things about neuropathy: what it feels like, why early matters, and what we do.

Tingling, numbness, or buttons get hard

Watch your fingertips and toes. Buttons, zippers, picking up coins, telling hot from cold — small daily tasks tell the truth before you'd think to mention it.

It builds with each dose

Paclitaxel neuropathy is cumulative. Symptoms tend to start mild around cycle two or three and can deepen. Caught early, we can adjust your dose. Caught late, some changes can stick around.

Tell us before you'd tell anyone else

Don't wait until it bothers you at night, or until you drop something. Even a 'maybe?' is enough. Reporting is not complaining — it's how we keep your hands working long after chemo ends.

Sources
  • openFDA paclitaxel: peripheral neuropathy is dose-limiting; cumulative; partially reversible if caught early
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-NEUR-01): functional examples (buttons, coins, temperature)
  • research/Interview-1: 'reporting is not complaining' framing

Three points: signs, mechanism (cumulative), action. Functional cues (buttons, coins) lower under-reporting. 'Some changes can stick around' is the honest motivation; not catastrophizing but not soft-pedaling either.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.neuropathy.acknowledge

For you

For ovarian patients on six cycles of carbo and paclitaxel, neuropathy commonly shows up around cycle two or three — first as a faint buzz in the toes, sometimes the fingertips. Most patients see it improve after treatment ends. The earlier we know, the more we can keep it that way.

For your support person

Watch for things she stops doing without saying: zippers, jewelry, certain shoes, picking up coins from the table. If you notice a pattern, mention it once at her next appointment — even if she said it was nothing. You're paying attention while she's adjusting.

Sources
  • openFDA paclitaxel: peripheral neuropathy median onset cycle 2-3 cumulative
  • research/Interview-2: caregiver-as-observer pattern for under-reported symptoms
  • research/Comprehension_Gaps: patients normalize early neuropathy as 'getting older'

Education priority. Patient context names the cycle 2-3 onset and improvement-after-treatment trajectory honestly. Caregiver context is observational specifics — she's noticing what the patient may not yet name.

CONFIRM Confirm understanding carbo-taxol.neuropathy.confirm

binary_decision

Cycle two. Your toes feel buzzy at night — not painful. Next visit is two weeks away. What now?

  • Wait — mention it next visit
  • Send a portal message now ←
Sources
  • openFDA paclitaxel: peripheral neuropathy is dose-limiting; early adjustment preserves function
  • research/Comprehension_Gaps: 'wait until next visit' is the dominant under-reporting pattern for neuropathy

Drug-pair scope per coverage matrix. Tests the 'wait for next visit' under-reporting wrong-answer. Mechanism explanation (dose adjustment window narrows with severity) makes urgency learnable.

HANDOFF Handoff with homework universal.neuropathy.handoff

One line to remember: Mild and early is the moment that matters. Tell us before you'd tell anyone else.

Homework: Once a week, do the 'button check' — fasten one button or pick up a coin. If anything feels harder than last week, log it.

▶ In-app action
log symptom
{
  "scale": "0_to_10",
  "symptom_type": "neuropathy"
}

Before you leave: Before you go — what's your weekly button-check day?

Sources
  • openFDA paclitaxel: peripheral neuropathy cumulative across taxane regimens
  • research/Interview-1: 'button check' weekly self-test for functional neuropathy
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-NEUR-01): functional probes

Universal scope: neuropathy management is regimen-agnostic for any taxane/platinum regimen. Button-check is a tiny, repeatable functional probe. Open_loop omitted (universal).

Cycle 1 · Day 14 EDUCATION gate: soft

Hair Loss

TUNE Tune in to readiness universal.hair_loss.tune

Hair loss is one of the hardest parts — not the hair itself, but how it makes the diagnosis visible. The hair returns. The strength behind this stays.

You've heard hair loss is coming. Knowing the timing makes it less of a surprise.

Question for you: What's been on your mind — wig, scarves, a haircut, or none of those?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Thanks — we'll get you what you need.
Sources
  • research/Emotional_Journey_Map: 'makes the diagnosis visible' — patient-validated framing
  • research/Interview-1: scaffold-on-familiar (already heard it's coming) plus assessment of patient's coping plan

Universal scope: hair loss is regimen-agnostic teaching. Avoids minimization ('it's just hair') and toughening ('be brave'). Names the actual hard part: visibility of the diagnosis. Open-text rapid assessment surfaces patient's existing plan (wig, haircut, etc.) for personalization.

EXPLAIN Explain essentials universal.hair_loss.explain

Three things to know: when, what to expect, and what comes back.

Around weeks two to three

For most chemotherapy that causes hair loss, you'll notice extra shedding two to three weeks after the first infusion. Many people choose to cut it short or shave first, on their own terms.

Scalp tenderness is normal

A few days before hair starts to come out, the scalp can feel tender or tingly. Soft pillowcases, satin caps at night, and gentle shampoo help. This passes.

Hair returns three to six months after

Once chemotherapy ends, hair starts growing back, typically within three to six months. It often comes in different at first — softer, sometimes a different texture or color. Most patients find it normalizes within a year.

Sources
  • openFDA paclitaxel: alopecia common; complete hair loss typical; reversible after treatment
  • research/Interview-1: 'on your own terms' framing for choice-restoring actions
  • research/Emotional_Journey_Map: scalp-tenderness as missed signal

Universal scope: timing is consistent across most hair-loss-causing chemotherapy. Three points: timing, what to expect, what returns. 'On your own terms' gives back agency. Honest about regrowth being different at first.

ACKNOWLEDGE Acknowledge emotion ovarian.hair_loss.acknowledge

For you

For ovarian patients, hair loss often coincides with the moment treatment starts to feel real — a few weeks in, when the surgery is behind you and the chemo rhythm is settling. It's a private grief that you don't have to make smaller. Cry about it. Plan around it. Both are right.

For your support person

Don't say 'it's only hair' or 'you'll look beautiful bald.' Either of those flattens what she's feeling. Better: ask 'what would help most this week?' and follow her lead. Buy the soft pillowcase before she asks. Sit with her if she wants to cut it short.

Sources
  • research/Emotional_Journey_Map: ovarian patients describe hair loss as 'when it got real' (post-debulking + early chemo)
  • research/Interview-1: caregiver anti-patterns ('it's only hair', 'you'll look beautiful bald') and replacements

Disease-site scope: the timing-with-treatment-becoming-real is specifically observed in ovarian patients post-debulking. Caregiver context names two specific anti-patterns and one replacement question. No emotional minimization.

CONFIRM Confirm understanding universal.hair_loss.confirm

walk_through

Walk through your plan for the day you decide to do something about your hair — cut it short, shave it, choose a wig or scarves, none of those. Whatever feels like yours.

[ patient types or speaks answer · "Submit" button ]
Sources
  • research/Interview-2: walk_through CONFIRM for non-judgmental personal-choice topics
  • research/Emotional_Journey_Map: agency-restoring actions reduce hair-loss distress

Universal scope. Walk_through (no graded answer) — hair-loss planning is personal choice, not knowledge testing. Correct_feedback affirms whatever the patient said. No incorrect_feedback (walk_through has no wrong answer).

HANDOFF Handoff with homework universal.hair_loss.handoff

One line to remember: It comes back. Until then, you choose how to meet this.

Homework: This week: pick up a satin pillowcase and a soft cap for sleep. Optional but it makes the scalp-tender days easier when they come.

Before you leave: Before you go — what is one thing you want to have ready before week three?

Sources
  • research/Interview-1: practical-prep homework reduces anticipatory distress
  • openFDA paclitaxel: scalp tenderness common before alopecia onset

Universal scope. Tiny, optional homework (one purchase) — agency-restoring without pressure. Exit ticket pulls forward planning to week-3 horizon. Open_loop omitted (universal).

Cycle 5 · Day 1 SAFETY gate: hard

Hypersensitivity

TUNE Tune in to readiness carbo-taxol.hypersensitivity.tune

Most people get all six cycles without trouble. A small number develop a sensitivity to carboplatin after multiple doses. We watch closely; you flag anything that feels off.

By cycle five, your body has gotten used to the rhythm. There's one new thing to watch for now that wasn't a worry at the start.

Question for you: Anything different about how your body has reacted in the last cycle or two?

[ patient types answer · "Submit" or "Skip" ]
After they submit: Thanks — we'll keep an eye on that.
Sources
  • openFDA carboplatin: anaphylactic-like reactions; risk increases with cumulative exposure
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-HSR-01): risk after 6+ doses
  • research/Interview-1: scaffold-on-familiar (rhythm of treatment by cycle 5)

Drug-pair scope. Distinct from infusion_reactions (acute first-dose). Cumulative hypersensitivity risk pattern. Open-text rapid assessment surfaces subtle prior-cycle changes that may signal sensitization.

EXPLAIN Explain essentials carbo-taxol.hypersensitivity.explain

Three things to know: why now, what to watch for, and what we do.

Risk grows after six doses

Carboplatin sensitivity tends to show up around cycle five or six and is more common with repeat treatment. Most patients still go through fine. Your team is now in 'watch closely' mode.

Same signs, faster onset

Watch for flushing, itching, hives, throat tightness, trouble breathing, or back pain. With sensitization, these can start within minutes of carboplatin starting — or even partway through, when earlier cycles were fine.

Reactions don't end treatment

If you react, the team stops the infusion and gives medications. Many patients can finish chemotherapy through a slow desensitization protocol, or switch to a similar drug. Reacting is not the end of the plan.

Sources
  • openFDA carboplatin: anaphylactic-like reactions within minutes of administration
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-HSR-01): risk patterns and management
  • research/Comprehension_Gaps: 'reaction = end of treatment' patient fear

Three points: timing, signs, action. Last point preempts the catastrophizing fear ('reacting means I can't be cured'). Honest that desensitization or drug-switch keep treatment on track.

ACKNOWLEDGE Acknowledge emotion ovarian-carbo-taxol.hypersensitivity.acknowledge

Before it happens

If something starts to happen at cycle five, you're going to second-guess it — 'I tolerated four cycles of this, this can't be it.' That second-guessing is exactly the moment to speak up. Sensitization is the body's pattern, not yours, and the earlier we catch it the more options stay on the table.

Practice scenario

Practice now: It's twelve minutes into your fifth carboplatin. Your face flushes, your back aches between the shoulder blades. Step 1: raise your hand. Step 2: 'Something's different from last cycle.' Step 3: let the team take it.

For you

For ovarian patients on six cycles of carbo, sensitization most often shows up at cycle five or six. The team will pre-medicate more aggressively if your prior cycles flagged anything. Reacting now is a manageable detour, not a stop — desensitization or a drug change keeps your plan moving.

For your support person

If you're with her at cycle five or six, sit at her line of sight. Watch for the flush before she names it. If she says 'this feels different,' or you see her face go red, ask the nurse to check immediately — don't filter.

Sources
  • openFDA carboplatin: anaphylactic-like reactions cumulative-risk pattern
  • app-content/chemo-cards/ovarian/carboplatin_paclitaxel.md (OV-TC-HSR-01): cycle 5-6 onset
  • research/interview-2: 'this can't be it' under-reporting pattern at late cycles
  • research/Interview-1/02_Storm_Prep_Checklist_Patient.md: generator drill

Safety priority — pre_rehearsal AND generator_drill present. Pre-rehearsal names the late-cycle 'I tolerated this before' under-reporting impulse, which is the dominant risk for hypersensitivity. Caregiver context targets the visual sign (flush) the patient may not yet feel.

CONFIRM Confirm understanding carbo-taxol.hypersensitivity.confirm

binary_decision

Cycle five. Ten minutes into carboplatin, your back aches between the shoulder blades. Last four cycles were fine. What now?

  • Wait — probably nothing
  • Tell the nurse — something's different ←
Sources
  • openFDA carboplatin: anaphylactic-like reactions cumulative-risk pattern
  • research/Comprehension_Gaps: 'I tolerated it before' under-reporting at late cycles

Drug-pair scope. Tests the dominant late-cycle wrong-answer pattern. Back-ache between shoulder blades is a classic carboplatin hypersensitivity early sign per FDA label.

HANDOFF Handoff with homework universal.hypersensitivity.handoff

One line to remember: Anything different from earlier cycles — flush, back ache, tightness — say so out loud, right then.

Homework: Before your next infusion, write one line about how the last cycle felt — start, middle, end. Bring it. Different-from-last-time is the signal we use.

Before you leave: Before you go — what's the one thing you say if cycle five feels different from cycle four?

Sources
  • openFDA carboplatin/paclitaxel: hypersensitivity cumulative-risk applies across platinum/taxane regimens
  • research/Interview-1: 'compare to last time' as observational frame

Universal scope: 'compare-to-last-time' is the universal observational frame for late-cycle hypersensitivity across regimens. Open_loop omitted (universal).

Overall feedback

Anything not section-specific — overall tone, structure, what's working, what isn't.